Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6030708

Cl.Nc1cnn(CCO)c1N

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KIT known ✓ P10721 1/20 0.32
CYP1A2 P05177 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19549166 1.00 CYP1A2 (0.41) CYP1A2SMN1; SMN2KITMAPTTSHR
SCHEMBL33881 0.98 CYP1A2 (0.42) CYP1A2SMN1; SMN2KITMAPTTSHR
Bromide SCHEMBL26106807 0.96 CYP1A2 (0.41) CYP1A2SMN1; SMN2KITMAPTTSHR
Sulfuric Acid SCHEMBL143344 0.89 CYP1A2 (0.36) CYP1A2
Sulfuric Acid SCHEMBL2854050 0.89 CYP1A2 (0.36) CYP1A2
SCHEMBL3952062 0.89 CYP1A2 (0.36) CYP1A2TSHR
Sulfuric Acid SCHEMBL8919999 0.87 CYP1A2 (0.35) CYP1A2SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6757419 0.87 TSHR (0.33) TSHR
SCHEMBL5398725 0.86 ADORA2A (0.33) CYP1A2
SCHEMBL2923881 0.84 TSHR (0.34) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634365-B1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO KGAA (DE) 2022-08-10 EP claimed
EP-3496818-B1 PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO KGAA (DE) 2021-01-20 EP claimed
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles HENKEL AG & CO. KGAA (DE) 2020-08-11 US claimed
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2020-06-04 US claimed
EP-3496818-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES Henkel AG & Co. KGaA (DE) 2019-06-19 EP claimed
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2019-06-13 US claimed
WO-2018028861-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2018-02-15 WO claimed
JP-2172988-A None JP disclosed
US-12622856-B2 Agent for oxidative dyeing of keratin fibers, containing isatin and at least one defined polymer HENKEL AG & CO. KGAA (DE) 2026-05-12 US disclosed
EP-4496557-A1 MEANS FOR OXIDATIVELY DYEING KERATIN FIBRES, CONTAINING AT LEAST ONE OXIDATION DYE PRECURSOR OF THE DEVELOPER TYPE, ISATIN AND AT LEAST ONE DETERMINED COMPLEXING AGENT Henkel AG & Co. KGaA (DE) 2025-01-29 EP disclosed
EP-4496558-A1 MEANS FOR OXIDATIVELY DYEING KERATIN FIBRES, CONTAINING AT LEAST ONE OXIDATION DYE PRECURSOR OF THE DEVELOPER TYPE, ISATIN AND AT LEAST ONE DETERMINED ALKALISING AGENT Henkel AG & Co. KGaA (DE) 2025-01-29 EP disclosed
EP-4496559-A1 AGENT FOR OXIDATIVE DYEING OF KERATIN FIBRES, CONTAINING ISATIN AND AT LEAST ONE DEFINED POLYMER Henkel AG & Co. KGaA (DE) 2025-01-29 EP disclosed
EP-4496556-A1 AGENT FOR OXIDATIVELY DYEING KERATIN FIBERS, CONTAINING AT LEAST ONE OXIDATION DYE PRECURSOR OF THE DEVELOPER TYPE, AT LEAST ONE OXIDATION DYE PRECURSOR OF THE COUPLER TYPE AND ISATIN Henkel AG & Co. KGaA (DE) 2025-01-29 EP disclosed
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2019-06-13 US disclosed
US-20190083372-A1 HAIR DYE HAVING IMPROVED VISCOSITY STABILITY HENKEL AG & CO. KGAA (DE) 2019-03-21 US disclosed
WO-2018224244-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2018-12-13 WO disclosed
WO-2018028861-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2018-02-15 WO disclosed
US-20060090270-A9 Novel 6-alkoxy-2, 3-diaminopyridine couplers in which the amino radical in position 2 is a disubstituted amino radical, and use of these couplers for dyeing keratin fibres VIDAL LAURENT 2006-05-04 US disclosed
US-20050086747-A1 Novel 6-alkoxy-2, 3-diaminopyridine couplers in which the amino radical in position 2 is a disubstituted amino radical, and use of these couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2005-04-28 US disclosed
JP-H02172988-A 1H-PYAZOLO(3,4-B)PYRAZINE DERIVATIVE AND ANTINEOPLASTIC AGENT CONTAINING THE SAME COMPOUND LION CORP 1990-07-04 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622856-B2 Agent for oxidative dyeing of keratin fibers, containing isatin and at least one defined polymer KRT18, ARSA, MKI67 KIT 413/4885CYP1A2 1171/4885SMN1; SMN2 4824/4885
US-20190083372-A1 HAIR DYE HAVING IMPROVED VISCOSITY STABILITY KRT18, S100B, SHH KIT 1173/4885CYP1A2 2761/4885SMN1; SMN2 2196/4885
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles EXOSC10, ANXA5, ANXA4 KIT 2467/4885CYP1A2 2777/4885SMN1; SMN2 4337/4885
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE UGCG, ADH1C, ELOVL1 KIT 3491/4885CYP1A2 1162/4885SMN1; SMN2 3053/4885
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES EXOSC10, ANXA5, ANXA4 KIT 2467/4885CYP1A2 2777/4885SMN1; SMN2 4337/4885
US-20060090270-A9 Novel 6-alkoxy-2, 3-diaminopyridine couplers in which the amino radical in position 2 is a disubstituted amino radical, and use of these couplers for dyeing keratin fibres KRT18, QDPR, PYCR1 KIT 2200/4885CYP1A2 1119/4885SMN1; SMN2 4198/4885
US-20050086747-A1 Novel 6-alkoxy-2, 3-diaminopyridine couplers in which the amino radical in position 2 is a disubstituted amino radical, and use of these couplers for dyeing keratin fibres KRT18, QDPR, PYCR1 KIT 2200/4885CYP1A2 1119/4885SMN1; SMN2 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.